New leukemia treatment enters first human safety tests
Disease control
Terminated
This is an early-stage study to check the safety and find the right dose of an experimental treatment called CT0991 for adults with acute myeloid leukemia that has returned or not responded to other therapies. It will involve up to 24 participants. The main goal is to see what si…
Phase: PHASE1 • Sponsor: He Huang • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC